Timetable - The World Congress On Controversies in Urology (CURy)

The 3rd World Congress on

Controversies in Urology (CURy)

Hilton Hotel, Athens, Greece, February 25-28, 2010

Timetable

Please note that the timetable is tentative and still subject to change

Thursday, February 25, 2010

19:30-21:00 Welcome reception

Friday, February 26, 2010
Time	Hall A	Hall B
08:30-10-00	Session 1 PROGRESS IN MINIMALLY INVASIVE SURGERY (MIS) An unrestricted educational grant by Olympus Medical Systems Europa (GMBH)	Session 2 PROSTATE CANCER: RISING PSA FAILURE AFTER TENTATIVE CURATIVE TREATMENT

10:00-10:30	Coffee Break and Poster Viewing
10:30-12:00	Session 3 MEASURING OUTCOMES IN OVER-ACTIVE BLASDDER (OAB): PAST, PRESENT & FUTURE An unrestricted educational grant by Astellas Pharma Europe Ltd.	Session 4 BLADDER CANCER: NON-MUSCLE INVASION An unrestricted educational grant by Kyowa Hakko Kirin

12:00-13:30	Session 5 DISCUSSION ON KEY CONTROVERSIES IN THE MANAGEMENT OF PROSTATE CANCER Satellite Symposium by Astellas Pharma Europe Ltd.

13:30-14:30	Lunch Break
14:30-16:00	Session 6 CONTROVERSIES IN THE MANAGEMENT OF MALE LUTS: go with the flow or go for the patient An unrestricted educational grant by Astellas Pharma Europe Ltd.	Session 7 TESTICULAR CANCER MANAGEMENT

16:00-16:30	Coffee Break and Poster Viewing
16:30-17:30	Session 8 PROSTATE CANCER PREVENTION, SCREENING AND EARLY DIAGNOSIS	Session 9 RENAL TUMORS: CASE DISCUSSION DEBATES

Saturday, February 27, 2010
Time	Hall A	Hall B
08:30-10:00	Session 10 NON-MUSCLE INVASIVE BLADDER CANCER Transurethral resection (TUR) quality control How to improve outcomes Controversies in the management of T-1 disease An unrestricted educational grant by General Electric (GE)	Session 11 MEN'S HEALTH Erectile dysfunction (ED), Testosterone deficiency (TD)

10:00-10:30	Coffee Break and Poster Viewing
10:30-12:00	Session 12 STRATEGIES FOR OPTIMIZING OUTCOMES GU MALIGNANCIES Supported by Novartis Oncology	Session 13 MINIMAL AND LOCALIZED PROSTATE CANCER

12:00-13:30	Session 14 GnRH RECEPTOR BLOCKADE: THE NEW APPROACH TO PROSTATE CANCER MANAGEMENT Agonists vs. antagonists An unrestricted educational grant by Ferring	Session 15 MALE URINARY INCONTINENCE

13:30-13:40	Best Abstract Award Ceremony (Hall A) sponsored by Pfizer Oncology
13:40-14:30	Lunch Break
14:30-16:00	Session 16 KEY CONTROVERSIES IN ADVANCED GU CANCERS An unrestricted educational grant by Sanofi Aventis	Session 17 ENDOUROLOGY & NEPHROLITHIASIS Sponsored in part by Karl Storz

16:00-16:30	Coffee Break and Poster Viewing
16:30-18:00	Session 18 BPH SURGICAL MANAGEMENT An unrestricted educational grant by American Medical Systems	Session 19 LOCALLY-ADVANCED BLADDER CANCER: CASE DISCUSSION

Sunday, February 28, 2010
Time	Hall A

09:00-10:30	Session 20 URINARY DIVERSION

10:30-11:00	Coffee Break
11:00-13:00	Session 21 LOOKING AT OUTCOMES Surgery for bladder & prostate cancer Open vs. Lap vs. Robotic

13:00-13:30	Drinks and Sandwiches